Research areas
Kura spins out Caspian to test menin inhibitors for diabetes
Kura Oncology has spun out a new biotech startup, Caspian Therapeutics, to develop menin inhibitor drugs for diabetes and cardiometabolic diseases.
#Oncology
Every Medical Research story tagged Oncology.
Research areas
Kura spins out Caspian with $50M to test menin inhibitor KO-7246
Kura Oncology has created spinout Caspian Therapeutics, backed by $50 million from investors including Eli Lilly, to advance menin inhibitor KO-7246.